Daily Health Headlines

Depressed Women Less Likely to Get Best Breast Cancer Care: Study

👤by Robert Preidt 0 comments 🕔Monday, November 21st, 2016

FRIDAY, Nov. 18, 2016 (HealthDay News) -- Breast cancer patients with a history of depression are less likely to receive recommended care for their disease, a new study finds.

The study included more than 45,000 Danish women diagnosed with early stage breast cancer between 1998 and 2011. Of those, 13 percent had been treated with antidepressants and 2 percent had previously visited a hospital for depression.

Compared with those who never took antidepressants, patients who used antidepressants were much less likely to receive recommended breast cancer treatments and had shorter overall survival, according to Dr. Nis Suppli, of the Danish Cancer Society Research Center in Copenhagen, Denmark, and colleagues.

In addition, the researchers found that antidepressant use was tied to shorter breast cancer-specific survival: five years after cancer diagnosis, 13 percent of patients who used antidepressants had died of breast cancer, compared to 11 percent of those who never took the drugs.

The study authors suggest that the lower survival rate among those who took antidepressants is due to the fact that they are less likely to receive recommended breast cancer treatments.

The findings were published online this week in the Journal of Clinical Oncology, a publication of the American Society of Clinical Oncology (ASCO).

"These findings suggest that women with prior depression may be vulnerable to receiving sub-standard breast cancer care," said Dr. Harold Burstein, an ASCO expert in breast cancer.

"While the reasons for this are unknown, this study serves as a call for clinicians to provide careful attention to the treatment and follow-up care of this population," Burstein said.

"Women with mental health needs may require assistance in making treatment decisions and navigating the health care system," he added in an ASCO news release.

-- Robert Preidt

Article Credits / Source

Robert Preidt / HealthDay

Robert Preidt wrote this story for HealthDay. HealthDay provides up to the minute breaking health news. Click here to view this full article from HealthDay.

SOURCE: American Society of Clinical Oncology, news release, Nov. 14, 2016

View More Articles From Robert Preidt 🌎View Article Website

Sponsored Product

Lunar Sleep for $1.95

Lunar Sleep for $1.95

People who have trouble sleeping typically have low levels of melatonin, so melatonin supplements seem like a logical fix for insomnia. There is a high demand for sleep aids, especially in the U.S. The National Health Interview Survey done in 2002, and again in 2007, found 1.6 million US adults were using complementary and alternative sleep aids for insomnia. Lunar Sleep was a top choice. Use Promo Code: Sleep2014 and only pay $1.95 S&H.

Get Lunar Sleep for $1.95

More Cancer Articles

No Benefit From Routine Thyroid Cancer Screening: Task Force

No Benefit From Routine Thyroid Cancer Screening: Task Force0

TUESDAY, Nov. 22, 2016 (HealthDay News) -- Doctors should not screen for thyroid cancer in patients who have no symptoms of the disease, according to a U.S. Preventive Services Task Force draft recommendation. It reaffirms a recommendation ...

Earnings Fall After a Child's Cancer Diagnosis

Earnings Fall After a Child's Cancer Diagnosis0

MONDAY, Nov. 21, 2016 (HealthDay News) -- After a child's cancer diagnosis, parents' income often drops and mothers frequently stop working, a new study finds. Moreover, the financial effects of a cancer diagnosis can last years, with mothers' ...

Monoclonal Antibodies

Monoclonal Antibodies0

home / cancer center / cancer a-z list / monoclonal antibodies index / monoclonal antibodies drug monograph Pharmacy Author: Omudhome Ogbru, PharmD Omudhome Ogbru, PharmDDr. Ogbru received his ...

New Drug May Brighten Outlook for Advanced Breast Cancer

New Drug May Brighten Outlook for Advanced Breast Cancer0

WEDNESDAY, Nov. 16, 2016 (HealthDay News) -- A recently approved drug can help slow the progression of advanced breast cancer, a new clinical trial confirms. The drug, called palbociclib (Ibrance), was approved in the United States last year ...

Exercise Good for Cancer Patients During, After Treatment

Exercise Good for Cancer Patients During, After Treatment0

TUESDAY, Nov. 15, 2016 (HealthDay News) -- Exercising during and after cancer treatment is safe and improves quality of life, fitness and physical functioning, new research indicates. Benefits occurred with all types of exercise, said study ...

View More Cancer Articles

0 Comments

Write a Comment

Your email address will not be published. Required fields are marked *

Our Mailing List

Subscribe to our mailing list to get the latest health news as it breaks!

Your information will not be shared with anyone!